PerkinElmer Inc. - Articles and news items

PerkinElmer Product Hub NEXION 2000 ICP/MS

Product Hub: PerkinElmer’s NexION® 2000 ICP-MS

Whitepapers / 2 May 2017 / PerkinElmer

The NexION® 2000 ICP-MS is designed to handle any sample matrix, address any interference, and detect any particle size. The system delivers enhanced matrix tolerance and low maintenance, which compresses workflows like never before, making small and high-throughput contract labs more productive in the process. A dynamic range from ppq to percent levels and a choice of modes and gases make it possible to analyse even the most difficult samples. And it comes preloaded with powerful methods that make it easy to set up and go…

Application note: Testing and validation of various antacids for class 1 and 2A elemental impurities

Application note: Testing and validation of various antacids for class 1 and 2A elemental impurities

Whitepapers / 18 April 2017 / PerkinElmer

In this paper, PerkinElmer present data to illustrate the successful validation of the NexION® 2000 ICP Mass Spectrometer for the determination of Class 1 and 2A elemental impurities in antacids according to USP General Chapter <233>…

Digital issue #2 in-depth focus mass spectrometry

Mass Spectrometry In-Depth Focus 2017

Issue 2 2017, Supplements, Z Homepage promo / 13 April 2017 / European Pharmaceutical Review

In this Mass Spectrometry In-Depth Focus: Mass spectrometry in the development of protein biologics; and GC-MS applications in pharmaceuticals analysis…

Application note: ICP-optical emission spectroscopy

Application note: ICP-optical emission spectroscopy

Whitepapers / 2 January 2017 / PerkinElmer

he U.S. Pharmocopeia is in the process of revising the analytical protocols for the analysis of metals in pharmaceutical products. A detailed summary of the methodology and the changes is available, so only a brief description will be given here…

Application Notes Whitepapers supplement 2016

Application Notes & Whitepapers 2016

Issue 6 2016, Supplements, Z Homepage promo / 13 December 2016 / European Pharmaceutical Review

With the huge range of processes involved in drug discovery and manufacture, it’s no wonder we had to create a separate magazine for this content – and as such we have a wide variety of applications…

PerkinElmer 60x60

PerkinElmer launches ChemDraw® cloud platform at 2016 ACS Fall National Meeting & Exposition

Supplier news / 2 September 2016 / PerkinElmer Inc

ChemDraw software moves to the cloud for enhanced collaboration among chemists and biologists…

PerkinElmer 60x60

PerkinElmer Signals™ Perspectives launches in collaboration with Attivio

Supplier news / 18 February 2016 / PerkinElmer Inc

New data discovery solution leverages Attivio’s platform to provide insight into complex scientific challenges…

Screening: In-depth focus 2013

Issue 3 2013, Screening, Supplements / 30 July 2013 / Anthony Mitchell Davies, Alice Vajda, Sarah Louise, Laure Marignol, Sheraz Gul, Emma J. Shanks

New approaches to cell based assays for high content screening and analysis.
Reduce, reuse, recycle: how drug repositioning is finding its niche in drug discovery.
Workshop Review: Biochemical assays for screening.
Screening roundtable.

Studying Cell Behaviour using a Phenotypic Approach

Video Interview: Studying Cell Behaviour using a Phenotypic Approach

Videos / 28 July 2013 / PerkinElmer Inc.

In this video interview, Dr. Chris Bakal from the Institute of Cancer Research, London, describes how his research group studies the shape changes of metastatic cells and how they spread through the body to cause disease. He explains how scientists perform high throughput RNA interference screens using the Opera® High Content Screening System, imaging millions of cells and quantifying individual shapes using a phenotypic approach…

PerkinElmer 60x60

PerkinElmer hosts Revolutionaries for Global Health Summit in Brussels

News, Supplier news / 1 March 2013 / Edelman (On behalf of PerkinElmer)

Revolutionaries for Global Health Summit, 5 -6 March 2013, Brussels

Practical Workshop – Biochemical Assays for Screening

Issue 1 2013 / 21 February 2013 / Sheraz Gul, Head of Biology at European ScreeningPort, Hamburg, Germany

Recent years have witnessed an expansion in the disciplines encompassing drug discovery outside the pharmaceutical industry. This is most notable with a significant number of universities worldwide that now host infrastructure such as compound libraries and automated screening centres[1-3]. An archetypal small molecule drug discovery project will aim to identify chemical starting points that modify the functions of genes, cells or biochemical pathways. In some, but not all instances, these functions may be linked to disease processes, and an opportunity will exist to further develop the probes into novel therapeutic agents. In small molecule drug discovery, the ultimate aim is to identify new therapeutics, an activity which for reasons of high risk and cost has historically been conducted within the commercial sectors[4].

PerkinElmer 60x60

PerkinElmer announces OneSource® Scientific IT Services to drive laboratory productivity growth

News, Supplier news / 25 June 2012 / Edelman (On behalf of PerkinElmer, Inc.)

PerkinElmer, Inc., has unveiled its OneSource® Scientific IT Services…

  • Page 1 of 2
  • 1
  • 2
  • >


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...